GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cassava Sciences Inc (MEX:SAVA) » Definitions » Cyclically Adjusted PB Ratio

Cassava Sciences (MEX:SAVA) Cyclically Adjusted PB Ratio : 4.09 (As of Jun. 25, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Cassava Sciences Cyclically Adjusted PB Ratio?

As of today (2024-06-25), Cassava Sciences's current share price is MXN356.00. Cassava Sciences's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was MXN87.14. Cassava Sciences's Cyclically Adjusted PB Ratio for today is 4.09.

The historical rank and industry rank for Cassava Sciences's Cyclically Adjusted PB Ratio or its related term are showing as below:

MEX:SAVA' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.07   Med: 1.13   Max: 9.9
Current: 4.65

During the past years, Cassava Sciences's highest Cyclically Adjusted PB Ratio was 9.90. The lowest was 0.07. And the median was 1.13.

MEX:SAVA's Cyclically Adjusted PB Ratio is ranked worse than
78.35% of 656 companies
in the Biotechnology industry
Industry Median: 1.615 vs MEX:SAVA: 4.65

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Cassava Sciences's adjusted book value per share data for the three months ended in Mar. 2024 was MXN30.161. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is MXN87.14 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Cassava Sciences Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Cassava Sciences's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cassava Sciences Cyclically Adjusted PB Ratio Chart

Cassava Sciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.93 1.68 10.39 6.92 5.16

Cassava Sciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.49 5.47 3.67 5.16 4.77

Competitive Comparison of Cassava Sciences's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Cassava Sciences's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cassava Sciences's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cassava Sciences's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Cassava Sciences's Cyclically Adjusted PB Ratio falls into.



Cassava Sciences Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Cassava Sciences's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=356.00/87.14
=4.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cassava Sciences's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Cassava Sciences's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=30.161/131.7762*131.7762
=30.161

Current CPI (Mar. 2024) = 131.7762.

Cassava Sciences Quarterly Data

Book Value per Share CPI Adj_Book
201406 86.612 100.560 113.499
201409 84.647 100.428 111.069
201412 90.388 99.070 120.228
201503 89.640 99.621 118.573
201506 86.276 100.684 112.919
201509 85.483 100.392 112.207
201512 77.252 99.792 102.012
201603 66.580 100.470 87.326
201606 64.492 101.688 83.574
201609 59.590 101.861 77.091
201612 58.291 101.863 75.409
201703 47.763 102.862 61.189
201706 36.369 103.349 46.373
201709 31.277 104.136 39.579
201712 28.881 104.011 36.591
201803 27.137 105.290 33.964
201806 24.353 106.317 30.185
201809 21.697 106.507 26.845
201812 22.382 105.998 27.825
201903 20.900 107.251 25.679
201906 19.882 108.070 24.243
201909 20.001 108.329 24.330
201912 19.082 108.420 23.193
202003 23.545 108.902 28.491
202006 22.401 108.767 27.140
202009 20.704 109.815 24.844
202012 52.047 109.897 62.409
202103 143.662 111.754 169.400
202106 137.549 114.631 158.121
202109 137.484 115.734 156.541
202112 130.166 117.630 145.820
202203 117.927 121.301 128.111
202206 109.561 125.017 115.485
202209 99.782 125.227 105.001
202212 106.291 125.222 111.855
202303 88.078 127.348 91.141
202306 73.350 128.729 75.086
202309 64.134 129.860 65.081
202312 55.246 129.419 56.252
202403 30.161 131.776 30.161

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Cassava Sciences  (MEX:SAVA) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Cassava Sciences Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Cassava Sciences's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Cassava Sciences (MEX:SAVA) Business Description

Traded in Other Exchanges
Address
6801 N. Capital of Texas Highway, Suite 300, Building 1, Austin, TX, USA, 78731
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms.

Cassava Sciences (MEX:SAVA) Headlines

From GuruFocus